Advertisement

Topics

Ovid Therapeutics (OVID) Cut to "Hold" at Zacks Investment Research

00:55 EDT 29 Mar 2018 | Topix

According to Zacks, "Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders.

Original Article: Ovid Therapeutics (OVID) Cut to "Hold" at Zacks Investment Research

NEXT ARTICLE

More From BioPortfolio on "Ovid Therapeutics (OVID) Cut to "Hold" at Zacks Investment Research"

Advertisement
Quick Search
Advertisement
Advertisement